ADC THERAPEUTICS SA shareholders Q2 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 57 filers reported holding ADC THERAPEUTICS SA in Q2 2023. The put-call ratio across all filers is 37.00 and the average weighting 0.2%.

ADC THERAPEUTICS SA shareholders Q2 2023
NameSharesValueWeighting ↓
Prosight Management, LP 11,167,800$24,010,7703.60%
Sio Capital Management, LLC 4,020,705$8,644,5162.20%
Redmile Group, LLC 14,049,935$30,207,3601.16%
Vantage Consulting Group Inc 885,520$1,903,8681.10%
Blue Owl Capital Holdings LP 733,568$1,577,1710.97%
AlphaCentric Advisors LLC 778,000$1,672,7000.93%
Affinity Asset Advisors, LLC 600,000$1,290,0000.45%
GCM Grosvenor Holdings, LLC 410,888$883,4090.38%
Indie Asset Partners, LLC 93,839$201,7540.22%
Frazier Life Sciences Management, L.P. 1,647,030$3,541,1150.21%
Nantahala Capital Management 840,000$1,806,0000.18%
XTX Topco Ltd 206,367$443,6890.08%
GSA CAPITAL PARTNERS LLP 108,885$2340.02%
ELCO Management Co., LLC 11,799$25,3680.02%
Hennion & Walsh Asset Management, Inc. 55,569$1190.01%
Miracle Mile Advisors, LLC 84,496$181,6660.01%
Magnetar Financial LLC 55,762$119,8880.00%
Cypress Capital Group 10,000$21,5000.00%
PICTET ASSET MANAGEMENT SA 1,270,132$2,730,7840.00%
Virtu Financial LLC 18,835$400.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q2 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.